(VGEU) Vanguard FTSE Developed - Ratings and Ratios
Equities, Europe, Large, Mid, Cap
Dividends
| Dividend Yield | 2.48% |
| Yield on Cost 5y | 4.24% |
| Yield CAGR 5y | 14.75% |
| Payout Consistency | 96.6% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 10.7% |
| Value at Risk 5%th | 18.3% |
| Relative Tail Risk | 4.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 9.54 |
| CAGR/Max DD | 0.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.600 |
| Beta | 0.131 |
| Beta Downside | 0.248 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.46% |
| Mean DD | 1.87% |
| Median DD | 1.32% |
Description: VGEU Vanguard FTSE Developed November 08, 2025
Vanguard FTSE Developed Europe UCITS ETF (ticker VGEU) is a Germany-domiciled, Europe-large-cap blend equity fund that tracks the Morningstar DM Eur TME NR EUR index. The ETF trades on XETRA, carries a low expense ratio of roughly 0.12 % p.a., and as of the latest reporting holds about €12 billion in assets under management. Its dividend yield sits near 2.5 % and the top ten holdings-dominated by Nestlé, Roche, ASML, LVMH and SAP-represent roughly 45 % of the portfolio.
Key macro-drivers for VGEU’s performance include the European Central Bank’s monetary stance, Eurozone GDP growth (forecast at 1.5 % YoY for 2025), and the region’s inflation trajectory, which influences sector rotation. The fund is weighted heavily toward consumer staples (≈18 %), health care (≈15 %), and industrials (≈14 %), sectors that historically exhibit lower volatility and benefit from steady demand even in a slowing economy. Recent data show that the FTSE Developed Europe index has outperformed the broader MSCI Europe benchmark by about 30 bps over the past 12 months, reflecting the relative strength of large-cap defensive stocks.
If you want a deeper, data-driven view of how VGEU’s risk-return profile stacks up against peers, the ValueRay platform offers granular analytics that can help you validate the assumptions behind these numbers.
What is the price of VGEU shares?
Over the past week, the price has changed by -0.14%, over one month by -1.03%, over three months by +4.59% and over the past year by +14.50%.
Is VGEU a buy, sell or hold?
What are the forecasts/targets for the VGEU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.5 | 14.9% |
VGEU Fundamental Data Overview December 12, 2025
Market Cap EUR = 4.10b (4.10b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.10b EUR (4.10b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 4.10b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 4.10b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.50% (E(4.10b)/V(4.10b) * Re(6.50%) + (debt-free company))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)